Evaluation of vaccine derived poliovirus type 2 outbreak response options: A randomized controlled trial, Karachi, Pakistan
Open Access
- 1 March 2018
- Vol. 36 (13) , 1766-1771
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Health’s Fogarty International Center (1 D43 TW007585-01)
This publication has 8 references indexed in Scilit:
- Immunogenicity of Different Routine Poliovirus Vaccination Schedules: A Randomized, Controlled Trial in Karachi, PakistanThe Journal of Infectious Diseases, 2017
- Fractional-Dose Inactivated Poliovirus Vaccine Immunization Campaign — Telangana State, India, June 2016MMWR. Morbidity and Mortality Weekly Report, 2016
- Progress Toward Polio Eradication — Worldwide, 2015–2016MMWR. Morbidity and Mortality Weekly Report, 2016
- Standardized Methods for Detection of Poliovirus Antibodies2016
- Immunogenicity and safety of a novel monovalent high-dose inactivated poliovirus type 2 vaccine in infants: a comparative, observer-blind, randomised, controlled trialThe Lancet Infectious Diseases, 2015
- The New Polio Eradication End Game: Rationale and Supporting EvidenceThe Journal of Infectious Diseases, 2014
- Priming after a Fractional Dose of Inactivated Poliovirus VaccineNew England Journal of Medicine, 2013
- Apparent global interruption of wild poliovirus type 2 transmission.2001